Global Escherichia Coli (E. Coli) Diagnostic Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 157560
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 135
  • list Pharmaceuticals and Healthcare

Escherichia coli (E. coli), is a bacterium which normally lives in the intestines of humans and animals.

Scope of the Report:

This report studies the Escherichia Coli (E. Coli) Diagnostic Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Escherichia Coli (E. Coli) Diagnostic Testing market by product type and applications/end industries.

Major sign and symptoms of E. coli infection include abdominal pain, diarrhea, and nausea and vomiting. Cases of E. coli infection are usually confirmed by the detection of bacteria in stool samples of infected individuals.

United States dominates the global E. coli diagnostic testing market. This is due to increased government funding on healthcare infrastructure in the region.

The E. coli diagnostic testing market in Asia is also expected to show high growth rates in the next five years. This is due to various initiatives undertaken by governments to increase awareness about E. coli infections.

The global Escherichia Coli (E. Coli) Diagnostic Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Escherichia Coli (E. Coli) Diagnostic Testing.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Abbott Laboratories

Beckman Coulter

Wako

Becton

Dickinson and Company

Affymetrix

bioMérieux

Bio-Rad Laboratories

Thermo Fisher Scientific

Siemens

Hoffmann-La Roche

Cepheid

GenBio

Olympus

Novartis

Johnson & Johnson

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monoclonal Antibodies

Molecular Diagnostics

Differential Light Scattering

Immunoassays

Flow Cytometry

Chromatography

Gel Microdroplets

Diagnostic Imaging

Market Segment by Applications, can be divided into

Commercial or Private Labs

Physician Offices

Hospitals

Public Health Labs

Academic Research Institutes

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Escherichia Coli (E. Coli) Diagnostic Testing Market Overview

1.1 Product Overview and Scope of Escherichia Coli (E. Coli) Diagnostic Testing

1.2 Classification of Escherichia Coli (E. Coli) Diagnostic Testing by Types

1.2.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Revenue Comparison by Types (2017-2023)

1.2.2 Global Escherichia Coli (E. Coli) Diagnostic Testing Revenue Market Share by Types in 2017

1.2.3 Monoclonal Antibodies

1.2.4 Molecular Diagnostics

1.2.5 Differential Light Scattering

1.2.6 Immunoassays

1.2.7 Flow Cytometry

1.2.8 Chromatography

1.2.9 Gel Microdroplets

1.2.10 Diagnostic Imaging

1.3 Global Escherichia Coli (E. Coli) Diagnostic Testing Market by Application

1.3.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Commercial or Private Labs

1.3.3 Physician Offices

1.3.4 Hospitals

1.3.5 Public Health Labs

1.3.6 Academic Research Institutes

1.4 Global Escherichia Coli (E. Coli) Diagnostic Testing Market by Regions

1.4.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Escherichia Coli (E. Coli) Diagnostic Testing Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Escherichia Coli (E. Coli) Diagnostic Testing Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Escherichia Coli (E. Coli) Diagnostic Testing Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Escherichia Coli (E. Coli) Diagnostic Testing Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Escherichia Coli (E. Coli) Diagnostic Testing Status and Prospect (2013-2023)

1.5 Global Market Size of Escherichia Coli (E. Coli) Diagnostic Testing (2013-2023)

2 Manufacturers Profiles

2.1 Abbott Laboratories

2.1.1 Business Overview

2.1.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Laboratories Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.2 Beckman Coulter

2.2.1 Business Overview

2.2.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Beckman Coulter Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.3 Wako

2.3.1 Business Overview

2.3.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Wako Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.4 Becton

2.4.1 Business Overview

2.4.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Becton Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.5 Dickinson and Company

2.5.1 Business Overview

2.5.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Dickinson and Company Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.6 Affymetrix

2.6.1 Business Overview

2.6.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Affymetrix Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.7 bioMérieux

2.7.1 Business Overview

2.7.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 bioMérieux Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.8 Bio-Rad Laboratories

2.8.1 Business Overview

2.8.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Bio-Rad Laboratories Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.9 Thermo Fisher Scientific

2.9.1 Business Overview

2.9.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Thermo Fisher Scientific Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.10 Siemens

2.10.1 Business Overview

2.10.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Siemens Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.11 Hoffmann-La Roche

2.11.1 Business Overview

2.11.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Hoffmann-La Roche Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.12 Cepheid

2.12.1 Business Overview

2.12.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Cepheid Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.13 GenBio

2.13.1 Business Overview

2.13.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 GenBio Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.14 Olympus

2.14.1 Business Overview

2.14.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Olympus Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.15 Novartis

2.15.1 Business Overview

2.15.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Novartis Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

2.16 Johnson & Johnson

2.16.1 Business Overview

2.16.2 Escherichia Coli (E. Coli) Diagnostic Testing Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Johnson & Johnson Escherichia Coli (E. Coli) Diagnostic Testing Revenue, Gross Margin and Market Share (2016-2017)

3 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Competition, by Players

3.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Escherichia Coli (E. Coli) Diagnostic Testing Players Market Share

3.2.2 Top 10 Escherichia Coli (E. Coli) Diagnostic Testing Players Market Share

3.3 Market Competition Trend

4 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Regions

4.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Market Share by Regions

4.2 North America Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

4.3 Europe Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

4.5 South America Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

5 North America Escherichia Coli (E. Coli) Diagnostic Testing Revenue by Countries

5.1 North America Escherichia Coli (E. Coli) Diagnostic Testing Revenue by Countries (2013-2018)

5.2 USA Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

5.3 Canada Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

5.4 Mexico Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

6 Europe Escherichia Coli (E. Coli) Diagnostic Testing Revenue by Countries

6.1 Europe Escherichia Coli (E. Coli) Diagnostic Testing Revenue by Countries (2013-2018)

6.2 Germany Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

6.3 UK Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

6.4 France Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

6.5 Russia Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

6.6 Italy Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Escherichia Coli (E. Coli) Diagnostic Testing Revenue by Countries

7.1 Asia-Pacific Escherichia Coli (E. Coli) Diagnostic Testing Revenue by Countries (2013-2018)

7.2 China Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

7.3 Japan Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

7.4 Korea Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

7.5 India Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

8 South America Escherichia Coli (E. Coli) Diagnostic Testing Revenue by Countries

8.1 South America Escherichia Coli (E. Coli) Diagnostic Testing Revenue by Countries (2013-2018)

8.2 Brazil Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

8.3 Argentina Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

8.4 Colombia Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Escherichia Coli (E. Coli) Diagnostic Testing by Countries

9.1 Middle East and Africa Escherichia Coli (E. Coli) Diagnostic Testing Revenue by Countries (2013-2018)

9.2 Saudi Arabia Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

9.3 UAE Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

9.4 Egypt Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

9.5 Nigeria Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

9.6 South Africa Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Growth Rate (2013-2018)

10 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Segment by Type

10.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Revenue and Market Share by Type (2013-2018)

10.2 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Forecast by Type (2018-2023)

10.3 Monoclonal Antibodies Revenue Growth Rate (2013-2023)

10.4 Molecular Diagnostics Revenue Growth Rate (2013-2023)

10.5 Differential Light Scattering Revenue Growth Rate (2013-2023)

10.6 Immunoassays Revenue Growth Rate (2013-2023)

10.7 Flow Cytometry Revenue Growth Rate (2013-2023)

10.8 Chromatography Revenue Growth Rate (2013-2023)

10.9 Gel Microdroplets Revenue Growth Rate (2013-2023)

10.10 Diagnostic Imaging Revenue Growth Rate (2013-2023)

11 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Segment by Application

11.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Revenue Market Share by Application (2013-2018)

11.2 Escherichia Coli (E. Coli) Diagnostic Testing Market Forecast by Application (2018-2023)

11.3 Commercial or Private Labs Revenue Growth (2013-2018)

11.4 Physician Offices Revenue Growth (2013-2018)

11.5 Hospitals Revenue Growth (2013-2018)

11.6 Public Health Labs Revenue Growth (2013-2018)

11.7 Academic Research Institutes Revenue Growth (2013-2018)

12 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast (2018-2023)

12.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size Forecast (2018-2023)

12.2 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Forecast by Regions (2018-2023)

12.3 North America Escherichia Coli (E. Coli) Diagnostic Testing Revenue Market Forecast (2018-2023)

12.4 Europe Escherichia Coli (E. Coli) Diagnostic Testing Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Escherichia Coli (E. Coli) Diagnostic Testing Revenue Market Forecast (2018-2023)

12.6 South America Escherichia Coli (E. Coli) Diagnostic Testing Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Escherichia Coli (E. Coli) Diagnostic Testing Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Escherichia Coli (E. Coli) Diagnostic Testing Picture

Table Product Specifications of Escherichia Coli (E. Coli) Diagnostic Testing

Table Global Escherichia Coli (E.

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery